Natixis Advisors LLC Purchases 170,566 Shares of CVS Health Co. (NYSE:CVS)

Natixis Advisors LLC raised its position in CVS Health Co. (NYSE:CVS - Free Report) by 25.2% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 846,208 shares of the pharmacy operator's stock after purchasing an additional 170,566 shares during the period. Natixis Advisors LLC owned approximately 0.07% of CVS Health worth $53,210,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Livelsberger Financial Advisory bought a new stake in shares of CVS Health in the third quarter worth about $31,000. Reston Wealth Management LLC bought a new stake in CVS Health during the 3rd quarter worth approximately $32,000. First Community Trust NA lifted its stake in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock valued at $33,000 after buying an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health in the third quarter valued at approximately $33,000. Finally, ORG Partners LLC increased its position in shares of CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator's stock worth $35,000 after acquiring an additional 592 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

CVS Health Trading Down 3.4 %

CVS Health stock traded down $1.90 during trading hours on Friday, hitting $53.19. The stock had a trading volume of 16,695,415 shares, compared to its average volume of 13,766,502. The stock has a market cap of $66.93 billion, a price-to-earnings ratio of 13.50, a P/E/G ratio of 0.92 and a beta of 0.55. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The business's 50 day simple moving average is $59.23 and its 200-day simple moving average is $58.66. CVS Health Co. has a one year low of $52.71 and a one year high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.21 EPS. On average, equities analysts predict that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 5.00%. CVS Health's payout ratio is 67.51%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a research note on Friday. Barclays lowered their price target on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th. Mizuho decreased their price objective on CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a report on Thursday, October 24th. Wells Fargo & Company dropped their target price on CVS Health from $61.00 to $60.00 and set an "equal weight" rating on the stock in a report on Monday, November 4th. Finally, TD Cowen upgraded CVS Health from a "hold" rating to a "buy" rating and raised their price target for the company from $59.00 to $85.00 in a research note on Friday, October 4th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $72.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.